Taiwan Semiconductor
TSM
Adobe
ADBE
Cisco
CSCO
4
Apple
AAPL
5
Netflix
NFLX
US Stock MarketDetailed Quotes
OGN Organon & Co
- 12.875
- -0.285-2.17%
Trading Apr 30 13:04 ET
3.32BMarket Cap3.87P/E (TTM)
13.075High12.810Low1.81MVolume13.035Open13.160Pre Close23.42MTurnover0.71%Turnover Ratio3.87P/E (Static)257.95MShares22.28852wk High7.04P/B3.31BFloat Cap10.45052wk Low1.12Dividend TTM256.82MShs Float33.352Historical High8.70%Div YieldTTM2.01%Amplitude10.015Historical Low12.936Avg Price1Lot Size
About Organon & Co Company
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Company Profile
SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com
Company Executives
- Name
- Position
- Salary
- Kevin Ali
- Chief Executive Officer and Director
- 17.12M
- Rachel A. Stahler
- Executive Vice President and Chief Digital & Growth Officer
- --
- Matthew M. Walsh
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 5.75M
- Aaron Falcione
- Executive Vice President and Chief Human Resources Officer
- --
- Dr. Juan Camilo Arjona Ferreira, M.D.
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 3.60M
- Kathryn DiMarco
- Senior Vice President and Corporate Controller
- --
- Vittorio Nisita
- Executive Vice President and Head of Enterprise Services & Solutions
- --
- Kirke Weaver
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Joseph T. Morrissey, Jr
- Executive Vice President and Head of Manufacturing and Supply
- 4.13M
- Daniel Karp
- Executive Vice President, Corporate Development
- --
- Carrie S. Cox
- Chairman of the Board
- 450.00K
- Ramona A. Sequeira
- Director
- --
- Shalini Sharp
- Independent Director
- 345.00K
- Rochelle B. Lazarus
- Independent Director
- 320.00K
- Grace Puma Whiteford
- Independent Director
- 320.00K
- Deborah R. Leone
- Independent Director
- 330.00K
- Cynthia M. Patton
- Independent Director
- 330.00K
- Robert A. Essner
- Independent Director
- 335.00K
- Dr. Philip Ozuah, M.D.,PhD
- Independent Director
- 334.06K
- Dr. Helene D. Gayle, M.D.
- Independent Director
- 320.00K
- Dr. Alan Ezekowitz, M.D.,PhD
- Independent Director
- 330.00K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call